Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease

Neurology

Volumn 46, Issue 3, 1996, Pages 707-719

  Morris, J C ^a,b   Storandt, M ^b   McKeel Jr , D W ^a   Rubin, E H ^a   Price, J L ^a   Grant, E A ^b   Berg, L ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; LONGITUDINAL STUDY; MALE; NEOCORTEX; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SENILE PLAQUE;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID; BRAIN; COGNITION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; REFERENCE VALUES;

EID: 0029892175     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.3.707     Document Type: Article

References (84)

1. Roush W. Protein studies try to puzzle out Alzheimer's tangles. Science 1995;267:793-794.
2. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.
3. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
4. Terry RD, Hansen LA, DeTeresa R, Davies P, Tobias H, Katzman R. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol 1987; 46:262-268.
5. Bancher C, Jellinger KA. Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects. Acta Neuropathol 1994;88:565-570.
6. Yankner BA, Mesulam MM. β-Amyloid and the pathogenesis of Alzheimer's disease. N Engl J Med 1991;325:1849-1857.
7. Rosenberg RN. A causal role for amyloid in Alzheimer's disease: the end of the beginning. 1993 American Academy of Neurology Presidential Address. Neurology 1993;43:851-856.
8. Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992;256:184-185.
9. Trojanowski JQ, Schmidt ML, Shin RW, Bramblett GT, Goedert M, Lee VM-Y. PHFτ(A68): from pathological marker to potential mediator of neuronal dysfunction and degeneration in Alzheimer's disease. Clin Neurosci 1993;1:184-191.
10. Crystal H, Dickson D, Fuld P, et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically con-firmed Alzheimer's disease. Neurology 1988;38:1682-1687.
11. Katzman R, Terry R, DeTeresa R, et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 1988;23:138-144.
12. Tagliavini F, Giaccone G, Frangione B, Bugiani O. Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals. Neurosci Lett 1988;93: 191-196.
13. Delaére P, Duyckaerts C, Masters C, Beyreuther K, Piette F, Hauw J-J. Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person. Neurosci Lett 1990;116:87-93.
14. Dickson D, Crystal HA, Mattiace LA, et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1991;13:179-189.
15. McKee AC, Kosik KS, Kowall NW. Neuritic pathology and dementia in Alzheimer's disease. Ann Neurol 1991;30:156-165.
16. Crystal HA, Dickson DW, Sliwinski MJ, et al. Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol 1993;34:566-573.
17. Delaére P, He Y, Fayet G, Duyckaerts C, Hauw J-J. βA4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centenarians. Neurobiol Aging 1993;14:191-194.
18. Von Dras DD, Blumenthal HT. Dementia of the aged: disease or atypical-accelerated aging? Biopathological and psychological perspectives. J Am Geriatr Soc 1992;40:285-294.
19. Berg L, McKeel DW Jr., Miller JP, Baty J, Morris JC. Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older. Arch Neurol 1993;50:349-358.
20. Coria F, Moreno A, Rubio I, García MA, Morato E, Mayor F. The cellular pathology associated with Alzheimer β-amyloid deposits in non-demented aged individuals. Neuropathol Appl Neurobiol 1993;19:261-268.
21. Morris JC, Fulling K. Early Alzheimer's disease. Diagnostic considerations. Arch Neurol 1988;45:345-349.
22. Rubin EH, Morris JC, Grant EA, Vendegna T. Very mild senile dementia of the Alzheimer type. I. Clinical assessment. Arch Neurol 1989;46:379-382.
23. Morris JC, McKeel DW Jr., Storandt M, et al. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 1991;41:469-478.
24. Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 1991; 12:295-312.
25. Price JL. The relationship between tangle and plaque formation during healthy aging and mild dementia. Neurobiol Aging 1993;14:661-663.
26. Berg L, Hughes CP, Danzinger WL, Martin RL, Knesevich J. Mild senile dementia of Alzheimer type (SDAT): research diagnostic criteria, recruitment, and description of a study population. J Neurol Neurosurg Psychiatr 1982;45:962-968.
27. Morris JC, McKeel DW, Fulling K, Torack RM, Berg L. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol 1988;24:17-22.
28. Berg L, Morris JC. Diagnosis. In: Terry RD, Katzman R, Bick K, eds. Alzheimer's disease. New York: Raven Press, 1994:9-25.
29. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114:797-811.
30. Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry 1983;140:734-739.
31. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975;23:433-441.
32. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
33. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
34. Burke WJ, Miller JP, Rubin EH, et al. Reliability of the Washington University Clinical Dementia Rating. Arch Neurol 1988;45:31-32.
35. McCulla MM, Coats M, Van Fleet N, Duchek J, Grant E, Morris JC. Reliability of clinical nurse specialists in the staging of dementia. Arch Neurol 1989;46:1210-1211.
36. Storandt M, Botwinick J, Danziger WL, Berg L, Hughes CP. Psychometric differentiation of mild senile dementia of the Alzheimer type. Arch Neurol 1984;41:497-499.
37. Storandt M, Hill RD. Very mild senile dementia of the Alzheimer type. II. Psychometric test performance. Arch Neurol 1989;46:383-386.
38. Wechsler D, Stone CP. Manual: Wechsler Memory Scale. New York: Psychological Corporation, 1973.
39. Benton AL. The revised visual retention test: clinical and experimental applications. New York: Psychological Corporation, 1963.
40. Wechsler D. Manual: Wechsler Adult Intelligence Scale. New York: Psychological Corporation, 1955.
41. Goodglass H, Kaplan E. The assessment of aphasia and related disorders. 2nd ed. Philadelphia: Lea & Febiger, 1983.
42. Thurstone LL, Thurstone LG. Examiner Manual for the SRA Primary Mental Abilities Test. Chicago: Science Research Associates, 1949.
43. Armitage SG. An analysis of certain psychological tests used in the evaluation of brain injury. Psych Mono 1946;60:1-48.
44. Botwinick J, Storandt M. Speed functions, vocabulary ability, and age. Percept Mot Skills 1973;36:1123-1128.
45. Davis PB, White H, Price JL, McKeel DW, Robins LN. Retrospective postmortem dementia assessment: validation of a new clinical interview to assist neuropathologic study. Arch Neurol 1991;48:613-617.
46. McKeel DW Jr., Ball MJ, Price JL, et al. Intel-laboratory histopathologic assessment of Alzheimer neuropathology: different methodologies yield comparable diagnostic results. Alzheimer Dis Assoc Disord 1993;7:136-151.
47. Nochlin D, Mackenzie AP, Bryant EM, Norwood TH, Sumi SM. A simple method of rapid freezing adequately preserves brain tissue for immunocytochemistry, light and electron microscopic examination. Acta Neuropathol 1993;86:645-650.
48. Hibbard LS, Arnicar-Sulze TL, McKeel DW, Burrell LD. Computed detection and quantitative morphometry of Alzheimer senile plaques. J Neurosci Methods 1994;52:175-189.
49. Braak H, Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1991;1:213-215.
50. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
51. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
52. Rudelli R, Strom JO, Welch PT, Ambler M. Posttraumatic premature Alzheimer's disease. Neuropathologic findings and pathogenetic considerations. Arch Neurol 1982;39:570-575.
53. Roberts GW, Allsop D, Bruton C. The occult aftermath of boxing. J Neurol Neurosurg Psychiatr 1990;53:373-378.
54. Hof PR, Bouras C, Buée L, Delacourte A, Perl DP, Morrison JH. Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia puglilistica and Alzheimer's disease cases. Acta Neuropathol 1992;85:23-30.
55. Kawarabayashi T, Shoji M, Harigaya Y, Yamaguchi H, Hirai S. Expression of APP in the early stage of brain damage. Brain Res 1991;563:334-338.
56. Ohgami T, Kitamoto T, Tateishi J. Alzheimer's amyloid precursor protein accumulates within axonal swellings in human brain lesions. Neurosci Lett 1992;136:75-78.
57. Roberts GW, Gentleman SM, Lynch A, Murray L, Landon M, Graham DI. β Amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1994;57:419-425.
58. Mann DMA, Jones D, Prinja D, Purkiss MS. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease. Acta Neuropathol 1990;80:318-327.
59. Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 1989;46:849-853.
60. Ulrich J. Alzheimer changes in nondemented patients younger than sixty-five: possible early stages of Alzheimer's disease and senile dementia of Alzheimer type. Ann Neurol 1985;17:273-277.
61. Linn RT, Wolf PA, Bachman DL, et al. The "preclinical phase" of probable Alzheimer's disease. Arch Neurol 1995;52:485-490.
62. Tierney MC, Snow WG, Reid DW, Zorzitto ML, Fisher RH. Psychometric differentiation of dementia. Replication and extension of the findings of Storandt and coworkers. Arch Neurol 1987;44:720-722.
63. Welsh KA, Butters N, Hughes JP, Mohs RC, Heyman A. Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol 1992;49:448-452.
64. Petersen RC, Smith GE, Ivnik RJ, Kokmen E, Tangalos EG. Memory function in very early Alzheimer's disease. Neurology 1994;44:867-872.
65. Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994;44:1427-1432.
66. Wisniewski HM, Rabe A, Zigman W, Silverman W. Neuropathological diagnosis of Alzheimer's disease. J Neuropathol Exp Neurol 1989;48:606-609.
67. Markesbery WR. The diagnosis of Alzheimer's disease. Arch Pathol Lab Med 1993;117:129-131.
68. Mirra SS, Gearing M, McKeel DW, et al. Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD). J Neuropathol Exp Neurol 1994;53:303-315.
69. Schmidt ML, DiDario AG, Lee VM-Y, Trojanowski JQ. An extensive network of PHF tau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer's disease. FEBS Lett 1994;344:69-73.
70. Kazee AM, Eskin TA, Lapham LW, Gabriel KR, McDaniel KD, Hamill RW. Clinicopathologic correlates in Alzheimer disease: assessment of clinical and pathologic criteria. Alzheimer Dis Assoc Disord 1993;7:152-164.
71. Duyckaerts C, Delaere P, Hauw JJ, et al. Rating of the lesions in senile dementia of the Alzheimer type: concordance between laboratories. A European multicenter study under the auspices of EURAGE. J Neurol Sci 1990;97:295-323.
72. Craik FIM. Memory functions in normal aging. In: Yanagihara T, Petersen RC, eds. Memory disorders, research and clinical practice. New York: Marcel Dekker, 1991:347-367.
73. Giannakopoulos P, Hof PR, Surini M, Michel JP, Bouras C. Quantitative immunohistochemical analysis of the distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of nonagenarians and centenarians. Acta Neuropathol 1993;85:602-610.
74. Miller DC. Is it time to reassess the pathological criteria for a diagnosis of Alzheimer's disease? Alzheimer Dis Assoc Disord 1993;7:129-131.
75. Bouras C, Hof PR, Morrison JH. Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes. Neurosci Lett 1993;153:131-135.
76. Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 1992;42:1681-1688.
77. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
78. Wilcock GK, Esiri MM. Plaques, tangles and dementia: a quantitative study. J Neurol Sci 1982;56:343-356.
79. Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss in the major correlate of cognitive impairment. Ann Neurol 1991; 30:572-580.
80. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42: 631-639.
81. Bierer LM, Hof PR, Purohit DP, et al. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol 1995;52:81-88.
82. Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, Davies P. Correlations of synaptic and pathologic markers with cognition in the elderly. Neurobiol Aging 1995;16:285-304.
83. Hof PR, Bierer LM, Perl DP, et al. Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year old patient with preclinical signs of dementia. Arch Neurol 1992;49:946-953.
84. Games D, Adams D, Alessandrini R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 1995;373:523-527.